The Airborne Heroes behind Organ Transplant Procurement

The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.

 

I Don’t Care seeks to bring conversations to the world that touch on many healthcare topics. For a completely unique take, host Kevin Stevenson welcomed Jessie Naor, COO of GrandView Aviation. GrandView Aviation is a Part 135 certified aircraft operator. They transport organs for transplant and offer private charters.

Naor described the company’s origins. “We’ve been in the organ transplant transportation business for 12 years, starting with one helicopter. We now have 10 airplanes and serve multiple locations across the U.S.”

Hospitals mostly use the flights for organs with the shortest cold-time, including hearts, livers, and lungs. A typical procurement involves two pilots and two healthcare workers. They start at the home hospital, fly to the donor, retrieve the organ post-surgery, and return to their base.

Naor then discussed the importance of the FAA (Federal Aviation Administration) Part 135. Part 135 is different from Part 125, used by commercial airlines. It corresponds with private commercial, non-scheduled aircraft operations, requiring specific safety and operational protocols. Until the last few years, many organ transplant operations didn’t fly under Part 135.

“They were just flying private with few regulations. Now, it’s changed because of medivac accidents. There’s always risk, and you can never mitigate it 100 percent, but you should always ask operators how they’re doing it,” Naor shared.

Naor and GrandView have a mission to educate the healthcare industry and beyond about best practices and safety. Naor is currently on an FAA committee making suggestions to handle crew safety and organ transplant.

When asked what’s next for organ transplant, Naor said, “We don’t yet have drones, but people in the industry are trying to figure it out. I could see as being helpful within large cities.”

Listen to Previous Episodes of MarketScale’s I Don’t Care Right Here!

Follow us on social media for the latest updates in B2B!

Image

Latest

personal branding
Personal Branding Now Drives B2B Success, Customer Trust, and Competitive Advantage
December 5, 2025

Personal branding has rapidly shifted from a “nice-to-have” to a strategic imperative in B2B marketing, reshaping how companies communicate, differentiate, and build trust. As industries evolve and professionals take on more dynamic, multi-stream careers, visibility and authenticity have become critical assets. Key findings from the Edelman + LinkedIn Thought Leadership Impact Report show that…

Read More
IT
Real-World IT Practices Are Streamlining AV Deployments and Raising the Bar for Consistency
December 4, 2025

For years, the AV industry has discussed the long-anticipated convergence with IT—but that shift is no longer theoretical. With cloud adoption accelerating, hybrid work normalizing, and organizations rebuilding digital infrastructure after years of rapid change, AV systems now sit squarely on the IT backbone. In fact, the majority of newly upgraded conference rooms require network-centric…

Read More
ROI
ROI Case Study
December 3, 2025

Denials are no longer a slow leak in the revenue cycle—they’re a fast-moving, rule-shifting game controlled by payers, and hospitals that don’t model denial patterns in real time end up budgeting around losses they could have prevented. PayerWatch’s four-digit, client-verified ROI in 2024 shows what happens when a hospital stops reacting claim by…

Read More
coverage
Clip 2 – Fighting for Coverage: One Patient’s Story
December 3, 2025

Health insurers love to advertise themselves as guardians of care, but the real story often begins when a patient’s life no longer fits neatly into a spreadsheet. In oncology especially, “coverage” isn’t a bureaucratic checkbox—it’s the fragile bridge between a treatment that finally works and a relapse that can undo years of grit…

Read More